Russia’s cancer vaccine could receive approval by August, allowing treatment to begin, the head of the Gamaleya Research Institute has said...

Overzealous hopes for Trump's crypto actions last week had primed the market for a pullback, but the decline could be already over, said Standard Chartered's Geoff Kendrick....

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero...